Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Monsanto Co. -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (1725)	3/19/1999 7:47:00 PM
From: silInv	Read Replies (1) \| Respond to of 2539

IMS HEALTH REPORTS CELEBREX U.S. PRESCRIPTIONS DISPENSED REACH 2 Business Wire March 19, 1999, 3:07 p.m. PT 79,183 in Second Week of March Business Editors & Health/Medical Writers LONDON--(BW HealthWire)--March 19, 1999-- For the First Time, Celebrex Prescriptions Written Surpass Viagra's In Comparable Period IMS HEALTH (NYSE:RX) today reported that for the week ending March 12 - its ninth week on the market -- total Celebrex prescriptions dispensed in the U.S. reached 279,183, up 5.8 percent from the previous week. For the first time, Celebrex prescriptions surpassed those written for Viagra in the comparable period in its product lifecycle: In its ninth week on the market, 210,857 prescriptions were dispensed for Viagra. IMS HEALTH's regular weekly prescription activity report covering the week ending March 12 becomes available on Monday, March 22. IMS HEALTH is the world's leading provider of information solutions to the pharmaceutical and healthcare industries. Since its introduction in the U.S., a total of 1.2 million Celebrex prescriptions have been dispensed. The majority of weekly Celebrex prescriptions continue to be new prescriptions, which represented 87 percent of prescribing for the week ending March 5. IMS HEALTH's weekly prescription tracking service provides comprehensive coverage of three U.S. retail channels -- chain drugstores, independent pharmacies and food stores with pharmacies -- and includes cash and Medicaid prescriptions as well as third-party reimbursement. The service also provides unique access to mail-order prescriptions, making it the most complete market tracking service covering the U.S. pharmaceutical industry. IMS HEALTH is the world's leading provider of information solutions to the pharmaceutical and healthcare industries. With more than $1.2 billion in 1998 revenue, IMS HEALTH operates in over 90 countries. IMS HEALTH is the largest pharmaceutical manufacturer information partner, with over 40 years' experience in the industry. Key products and services integral to customer day-to-day operations include: market research for prescription and over-the-counter pharmaceutical products; sales management information to optimize sales force productivity; technology-enabled selling solutions for sales and marketing decision making; and technology systems and information services that support managed care organizations. Additional information and previous press releases are available at the IMS HEALTH website: imshealth.com.